Drug Pipeline

Sintilimab injection Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
4
Recruiting
1
Phase 3
4
Top Sponsors
Active Studies by Phase
Phase 2/3
1
Phase 1/2
1
Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07319429 Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular… Endometrial Cancer Recruiting
Phase 1/2
NCT06530251 A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC) Hepatocellular Carcinoma Recruiting
Phase 1
NCT07455617 Study of ABO2102 in KRAS-Mutated Solid Tumors Advanced / Metastatic Solid Tumor Recruiting
Not specified
NCT06353646 XH001 Combination With Immunocheckpoint Inhibitor and Chemotherapy for Patients With… Pancreatic Cancer Recruiting
Sponsors Running Sintilimab injection Trials
Wu Wenming (1) Akeso (1) Fudan University (1) Suzhou Abogen Biosciences Co., Ltd. (1)
Disease Areas
Pancreatic Cancer (1) Liver Cancer (1) Endometrial Cancer (1)
Get alerts when Sintilimab injection trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free